{"id":66463,"date":"2026-01-17T08:52:02","date_gmt":"2026-01-17T07:52:02","guid":{"rendered":"https:\/\/www.parkinson-hotline.com\/parkinson\/blog\/was-bedeutet-neuroplastizitaet-bei-parkinson-wirklich-copy\/"},"modified":"2026-02-03T04:18:33","modified_gmt":"2026-02-03T03:18:33","slug":"ko-isti-nozime-neiroplasticitate-parkinsona-slimibas-gadijuma-kopija","status":"publish","type":"post","link":"https:\/\/www.parkinson-hotline.com\/lv\/was-bedeutet-neuroplastizitaet-bei-parkinson-wirklich-copy\/","title":{"rendered":"Can the progression of Parkinson’s disease be slowed down?"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Vai var pal\u0113nin\u0101t Parkinsona slim\u012bbas progres\u0113\u0161anu?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0<\/p>


Ievads<\/strong>

Viens no visbie\u017e\u0101k uzdotajiem jaut\u0101jumiem cilv\u0113kiem ar Parkinsona slim\u012bbu un vi\u0146u tuviniekiem ir:
\u201cVai slim\u012bbas progres\u0113\u0161anu var pal\u0113nin\u0101t?\u201d<\/strong><\/p>

Parkinsona slim\u012bba pa\u0161laik ir ne\u0101rst\u0113jama. Tom\u0113r medic\u012bniskie atkl\u0101jumi liecina, ka da\u017eas terapeitisk\u0101s pieejas var pozit\u012bvi ietekm\u0113t slim\u012bbas funkcion\u0101lo progres\u0113\u0161anu.<\/p>

M\u0113r\u0137tiec\u012bgi vingrin\u0101jumi, motorikas m\u0101c\u012b\u0161an\u0101s un individu\u0101li piel\u0101gotas m\u0101c\u012bbas.<\/strong> ir galven\u0101 noz\u012bme - t\u0101pat k\u0101 specializ\u0113tajos terapijas veidos, piem\u0113ram, GIGER\u00ae MD\u00ae terapij\u0101.<\/p>

\u00a0<\/p>

\u00a0<\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Ko paties\u012bb\u0101 noz\u012bm\u0113 \u201cpal\u0113nin\u0101t progresu\u201d?<\/strong><\/p>

Run\u0101jot par Parkinsona slim\u012bbas progres\u0113\u0161anu, m\u0113s nerun\u0101jam par pa\u0161as slim\u012bbas aptur\u0113\u0161anu, bet gan par:<\/p>

  • p\u0113c iesp\u0113jas ilg\u0101k saglab\u0101t mobilit\u0101ti,<\/li>
  • funkcion\u0101lo ierobe\u017eojumu aizkav\u0113\u0161ana,<\/li>
  • dro\u0161\u012bbas un neatkar\u012bbas palielin\u0101\u0161ana ikdienas dz\u012bv\u0113.

    <\/li><\/ul>

    Progres\u0113\u0161ana ir \u013coti at\u0161\u0137ir\u012bga atkar\u012bb\u0101 no cilv\u0113ka. Iz\u0161\u0137iro\u0161ais faktors ir tas, cik agri un cik m\u0113r\u0137tiec\u012bgi tiek \u012bstenoti atbalsta pas\u0101kumi.<\/p>


    K\u0101di faktori ietekm\u0113 Parkinsona slim\u012bbas progres\u0113\u0161anu?<\/strong><\/p>

    Parkinsona slim\u012bbas progres\u0113\u0161anu cita starp\u0101 ietekm\u0113:<\/p>

    • slim\u012bbas s\u0101kums un veids,<\/li>
    • \u0123en\u0113tiskie un biolo\u0123iskie faktori,<\/li>
    • z\u0101\u013cu terapija,<\/li>
    • aktivit\u0101tes l\u012bmeni un kust\u012bbu uzved\u012bbu.

      <\/li><\/ul>

      Lai gan biolo\u0123iskos faktorus nevar ietekm\u0113t, m\u0113r\u0137tiec\u012bga vingrojumu terapija var sniegt b\u016btisku ieguld\u012bjumu.<\/p>

      \u00a0
      K\u0101da noz\u012bme ir vingrin\u0101jumiem?<\/strong><\/p>

      Tagad fizisk\u0101s aktivit\u0101tes tiek uzskat\u012btas par Parkinsona slim\u012bbas \u0101rst\u0113\u0161anas galveno sast\u0101vda\u013cu. P\u0113t\u012bjumi liecina, ka regul\u0101ras, struktur\u0113tas fizisk\u0101s aktivit\u0101tes:<\/p>

      • var ilg\u0101k saglab\u0101t mobilit\u0101ti,<\/li>
      • stabiliz\u0113 ikdienas funkcijas,<\/li>
      • var samazin\u0101t kritienu risku.<\/li><\/ul>

        Tom\u0113r ne visi vingrin\u0101jumi ir vienl\u012bdz efekt\u012bvi. Iz\u0161\u0137iro\u0161ais faktors ir tas, vai vingrin\u0101jumi ir m\u0113r\u0137tiec\u012bgi, apzin\u0101ti un orient\u0113ti uz m\u0101c\u012b\u0161anos.<\/p>

        \u00a0
        K\u0101p\u0113c m\u0113r\u0137tiec\u012bga apm\u0101c\u012bba ir svar\u012bg\u0101ka nek\u0101 t\u012bra aktivit\u0101te<\/strong><\/p>

        Pastaigas vai visp\u0101r\u0113jas aktivit\u0101tes ir noder\u012bgas, bet bie\u017ei vien ar t\u0101m nepietiek, lai pan\u0101ktu ilgsto\u0161us funkcion\u0101lus uzlabojumus.
        T\u0101p\u0113c modern\u0101s terapeitisk\u0101s pieejas, piem\u0113ram, GIGER\u00ae MD\u00ae terapija, koncentr\u0113jas uz:<\/p>

        • akt\u012bvas, apzin\u0101ti kontrol\u0113tas kust\u012bbu sekvences,<\/li>
        • sare\u017e\u0123\u012btas koordin\u0101cijas un l\u012bdzsvara pras\u012bbas,<\/li>
        • ritmiskas un struktur\u0113tas kust\u012bbu sh\u0113mas,<\/li>
        • individu\u0101li piel\u0101goti m\u0101c\u012bbu stimuli.

          <\/li><\/ul>

          M\u0113r\u0137is ir \u012bpa\u0161i izaicin\u0101t nervu sist\u0113mu un p\u0113c iesp\u0113jas ilg\u0101k stabiliz\u0113t funkcion\u0101l\u0101s sp\u0113jas.
          \u00a0<\/p>

          Saikne ar neiroplasticit\u0101ti<\/strong><\/p>

          Pat ar Parkinsona slim\u012bbu smadzenes joproj\u0101m sp\u0113j m\u0101c\u012bties. \u0160o piel\u0101go\u0161an\u0101s sp\u0113ju sauc par neiroplasticit\u0101ti.
          GIGER\u00ae MD\u00ae terapija izmanto \u0161o principu, izmantojot:<\/p>

          • vienlaic\u012bgi piev\u0113rsties vair\u0101k\u0101m ma\u0146u un kust\u012bbu sist\u0113m\u0101m,<\/li>
          • apvienojot koordin\u0113tas un ritmiskas kust\u012bbas,<\/li>
          • akt\u012bvi veicina motorisko m\u0101c\u012b\u0161anos.<\/li><\/ul>

            Neiroplasticit\u0101te nenoz\u012bm\u0113 iz\u0101rst\u0113\u0161anu, bet gan lab\u0101ku eso\u0161o nervu resursu izmanto\u0161anu.<\/p>

            \u00a0
            K\u0101di ir ierobe\u017eojumi?<\/strong><\/p>


            Lai cik svar\u012bga b\u016btu m\u0113r\u0137tiec\u012bga vingrojumu terapija, t\u0101 nevar aizst\u0101t \u0101rst\u0113\u0161anu. Parkinsona slim\u012bba joproj\u0101m ir progres\u0113jo\u0161a neirolo\u0123iska slim\u012bba. T\u0101p\u0113c m\u0113r\u0137is ir nevis iz\u0101rst\u0113t slim\u012bbu, bet gan:<\/p>

            • pal\u0113nin\u0101t funkcion\u0101lo lejupsl\u012bdi,<\/li>
            • p\u0113c iesp\u0113jas ilg\u0101k saglab\u0101t dz\u012bves kvalit\u0101ti,<\/li>
            • veicin\u0101t dro\u0161\u012bbu un neatkar\u012bbu ikdienas dz\u012bv\u0113.<\/li><\/ul>

              Terapeitisk\u0101s pieejas, piem\u0113ram, GIGER\u00ae MD\u00ae terapija, ir j\u0101uztver k\u0101 papildu, atbalsto\u0161i pas\u0101kumi.<\/p>

              \u00a0
              Secin\u0101jums<\/strong><\/p>

              Parkinsona slim\u012bba ir ne\u0101rst\u0113jama. Tom\u0113r slim\u012bbas skartie cilv\u0113ki var akt\u012bvi pal\u012bdz\u0113t pozit\u012bvi ietekm\u0113t slim\u012bbas funkcion\u0101lo gaitu.
              Regul\u0101ras, m\u0113r\u0137tiec\u012bgas fizisk\u0101s aktivit\u0101tes - \u012bpa\u0161i struktur\u0113tas terapijas veid\u0101, piem\u0113ram, GIGER\u00ae MD\u00ae terapija - var pal\u012bdz\u0113t ilg\u0101k saglab\u0101t mobilit\u0101ti, koordin\u0101ciju un dro\u0161\u012bbu ikdienas dz\u012bv\u0113.

              Autors: Combo AG, GIGER\u00ae MD\u00ae terapijas ra\u017eot\u0101js un izplat\u012bt\u0101js Medical<\/strong> \u2028
              Piez\u012bme: \u0160is raksts ir paredz\u0113ts tikai informat\u012bviem nol\u016bkiem un neaizst\u0101j medic\u012bnisku konsult\u0101ciju vai \u0101rst\u0113\u0161anu.
              P\u0113d\u0113jais atjaunin\u0101jums: 2026<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

              Can the progression of Parkinson’s disease be slowed down? \u00a0 Introduction One of the most common questions asked by people with Parkinson’s disease and their relatives is:\u201cCan the progression of the disease be slowed down?\u201d Parkinson’s disease is currently incurable. However, medical findings show that certain therapeutic approaches can have a positive effect on the […]<\/p>\n","protected":false},"author":1,"featured_media":66355,"comment_status":"closed","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[7354,7355],"tags":[],"class_list":["post-66463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en","category-parkinson-en"],"_links":{"self":[{"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/posts\/66463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/comments?post=66463"}],"version-history":[{"count":11,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/posts\/66463\/revisions"}],"predecessor-version":[{"id":66673,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/posts\/66463\/revisions\/66673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/media\/66355"}],"wp:attachment":[{"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/media?parent=66463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/categories?post=66463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/lv\/wp-json\/wp\/v2\/tags?post=66463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}